ARLINGTON, Va., Sept. 12 /PRNewswire/ -- The Science Advisory Board (http://www.scienceboard.net), a professional social network of more than 34,000 scientists, celebrates its ten-year anniversary -- making it one of the most enduring communities on the Web.
The Science Advisory Board is a division of BioInformatics, LLC (http://www.gene2drug.com), a research and advisory firm serving more than 300 clients in the biotechnology, pharmaceutical, IT, scientific publishing and finance industries.
The Science Advisory Board Website was launched on September 12, 1997 with the goal of helping bridge the gap between the manufacturers and end-users of instruments, products and services used in advanced biological research and drug discovery.
The Science Advisory Board was created because the traditional concept of a scientific advisory board often fails to accurately reflect the experiences, preferences and unmet needs of those professionals who actually use the products manufactured by industry. By utilizing the Web as a communications medium, The Science Advisory Board provides life scientists “in the trenches” with a prominent voice that helps drive the development of new tools and technologies for basic and applied research.
Scientists accepted for membership on the Board reap both professional and personal rewards. The Website boasts tens of thousands of pages of u ser-generated content in the form of scientific white papers, blogs, and a discussion forum where scientists can seek and offer advice. Members also submit reviews of hundreds of new products, books, databases and websites. Through a unique Honoraria program, members accumulate ViewPoints each time they participate in The Science Advisory Board’s activities. ViewPoints can then be redeemed for gifts or used in the form of charitable donations.
“A decade before people started talking about Web 2.0, our philosophy has always been to provide our members with the online tools that help them conduct their research more effectively,” commented Tamara Zemlo, Ph.D., M.P.H., and Chair of the Board’s Steering Committee. “By enabling scientists to collaborate with each other and to share their experiences with the community, we have created an indispensable resource used daily in labs around the world.”
ABOUT THE SCIENCE ADVISORY BOARD
The Science Advisory Board (http://www.scienceboard.net) is an online panel of more than 34,000 scientists and biomedical researchers from 62 countries. Members are scientific experts on the cutting edge of their disciplines and available to share in-depth knowledge of related technologies and discuss emerging trends. While their technical capabilities are broad given the multidisciplinary nature of scientific research, their insights are focused on specific areas of expertise. These areas of expertise include-but are not limited to-bioinformatics, biotechnology, cell biology, drug discovery, genetics, immunology, microbiology, molecular biology, neuroscience, pharmacology, physiology, and virology.
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and consulting firm serving the life science tools industry. By leveraging our global online panel of tens of thousands of biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning.
For more information, please contact: Dr. Tamara Zemlo The Science Advisory Board 2111 Wilson Blvd, Suite 250 Arlington, VA 22201 703.778.3080 x25 (phone) t.zemlo@scienceboard.nethttp://www.scienceboard.net Bill Kelly BioInformatics, LLC 2111 Wilson Blvd., Suite 250 Arlington, VA 22201 703.778.3080 x15 (phone) b.kelly@gene2drug.comhttp://www.gene2drug.com/
The Science Advisory Board
CONTACT: Dr. Tamara Zemlo of The Science Advisory Board, +1-703-778-3080x25, t.zemlo@scienceboard.net, or Bill Kelly of BioInformatics, LLC,+1-703-778-3080 x15, b.kelly@gene2drug.com
